The Inflammatory Bowel Disease (IBD) market is a subset of the Gastroenterology market, which focuses on the diagnosis and treatment of diseases related to the digestive system. IBD is a chronic condition that affects the digestive tract, causing inflammation and pain. Symptoms of IBD can include abdominal pain, diarrhea, rectal bleeding, and weight loss. Treatment options for IBD include medications, lifestyle changes, and surgery. IBD is a growing market, with an increasing number of patients seeking treatment. The market is expected to continue to grow as new treatments become available and awareness of the condition increases. Companies in the IBD market include AbbVie, Allergan, AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Pfizer, and Takeda. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
